Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jul 30, 2025 (15 months ago)

B12 Hydroxocobalamin for Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

B12 Hydroxocobalamin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Drug: Hydroxocobalamin

Recalling firm
GenoGenix LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0042-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Hydroxocobalamin recalls

See all
Class II · Moderate risk

Hydroxocobalamin B12

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0080-30 D-0826-2022

Other recalls by GenoGenix LLC

All 2025 recalls